Skip to content
StockMarketAgent
Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

ETR/CBHD stock hub

ETR/CBHD has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

ETR/CBHDis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
12.1B
Deutsche Börse Xetra
Market data

Live price

Current market quote for this ticker.

Current price
ETR/CBHD
In the news

Latest news · ETR/CBHD

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15.8
P25 12.3P50 15.7P75 20.2
Trailing P/E22.7
P25 16.4P50 20.9P75 30.4
ROE27.3
P25 -6.7P50 8.5P75 17.2
ROIC13.1
P25 -1.7P50 8.5P75 17.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All ETR/CBHD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
233
Groups with data
11
Currency
DKK
Showing 233 of 233 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Denmark
Country code
DE
Employees
16,983
Employees Change
355%
Employees Change Percent
2.13
Enterprise value
EUR 15.3B
Exchange
Deutsche Börse Xetra
Financial currency
DKK
First seen
2026-05-10
Industry
Medical Instruments & Supplies
Isin
DK0060448595
Last refreshed
2026-05-10
Market cap
EUR 12.1B
Price
EUR 54.44
Price currency
EUR
Rev Per Employee
219,896.91x
Sector
Healthcare
Sic
3842
Symbol
etr/CBHD
Website
https://www.coloplast.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
4.4%
EV Earnings
28.72x
EV/EBIT
14.97x
EV/EBITDA
12.92x
EV/FCF
20.94x
EV/Sales
4.11x
FCF yield
6.04%
Forward P/E
15.84x
P/B ratio
6.56x
P/E ratio
22.72x
P/S ratio
3.25x
PE Ratio10 Y
41.66x
PE Ratio3 Y
36.45x
PE Ratio5 Y
39.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

27
MetricValue
EBIT Margin
27.46%
EBITDA Margin
30.78%
FCF margin
19.62%
Gross margin
67.87%
Gross Profit
EUR 2.5B
Gross Profit Growth
2.24%
Gross Profit Growth Q
-0.32%
Gross Profit Growth3 Y
5.45%
Gross Profit Growth5 Y
8.47%
Net Income
EUR 534.1M
Net Income Growth
-18.33%
Net Income Growth Q
33.81%
Net Income Growth Quarters
1%
Net Income Growth Years
0%
Net Income Growth3 Y
-4.82%
Net Income Growth5 Y
-1.22%
Pretax Margin
22.15%
Profit Margin
14.3%
Profit Per Employee
EUR 31,450
Profitable Years
24
ROA
9.85
Roa5y
14.56
ROCE
18.74
ROE
27.26
Roe5y
41.31
ROIC
13.08
Roic5y
25.13

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

28
MetricValue
Cagr10y
-0.44%
Cagr1y
-34.02%
Cagr3y
-23.21%
Cagr5y
-14.38%
Div CAGR10
16.48%
Div CAGR3
4.63%
Div CAGR5
4.96%
EPS Growth
-18.41
EPS Growth Q
33.91
EPS Growth Quarters
1
EPS Growth Years
0
EPS Growth3 Y
-6.65
EPS Growth5 Y
-2.3
FCF Growth
207.88%
FCF Growth Q
7.63%
FCF Growth3 Y
16%
FCF Growth5 Y
6.23%
OCF Growth
130.18%
OCF Growth Q
11.26%
OCF Growth10 Y
7.54%
OCF Growth3 Y
15.54%
OCF Growth5 Y
6.82%
Revenue Growth
1.61x
Revenue Growth Q
0.24x
Revenue Growth Quarters
1x
Revenue Growth Years
23x
Revenue Growth3 Y
5.85x
Revenue Growth5 Y
8.48x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
EUR 0.57
Assets
EUR 6.5B
Cash
EUR 150.6M
Current Assets
EUR 1.4B
Current Liabilities
EUR 1.1B
Debt
EUR 3.4B
Debt EBITDA
EUR 2.83
Debt Equity
EUR 1.82
Debt FCF
EUR 4.59
Equity
EUR 1.8B
Interest Coverage
10.74
Liabilities
EUR 4.7B
Long Term Assets
EUR 5.2B
Long Term Liabilities
EUR 3.6B
Net Cash
EUR -3.2B
Net Cash By Market Cap
EUR -26.45
Net Debt EBITDA
EUR 2.79
Net Debt Equity
EUR 1.74
Net Debt FCF
EUR 4.38
Tangible Book Value
EUR -2.2B
Tangible Book Value Per Share
EUR -9.74
WACC
5.9

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.3
Inventory Turnover
2.38
Net Working Capital
EUR 662.5M
Quick ratio
0.76
Working Capital
EUR 317.3M
Working Capital Turnover
EUR -258

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
-0.17%
Dividend Growth
4.37%
Dividend Growth Years
10%
Dividend per share
EUR 3.08
Dividend Years
7
Dividend Yield
5.66%
Ex Div Date
2025-12-05
Last Dividend
EUR 2.41
Payout Frequency
Semi-Annual
Payout Ratio
129.96%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
10Y total return
-4.29%
1Y total return
-34%
200-day SMA
72.36
3Y total return
-54.72%
50-day SMA
58.39
50-day SMA vs 200-day SMA
50under200
5Y total return
-53.99%
All Time High
160.6
All Time High Change
-66.1%
All Time High Date
2021-11-22
All Time Low
51.9
All Time Low Change
4.89%
All Time Low Date
2026-04-30
ATR
1.38
Beta
0.5
Ch YTD
-25.49
High
54.96
High52
87.58
High52 Date
2025-05-08
High52ch
-37.84%
Low
54
Low52
51.9
Low52 Date
2026-04-30
Low52ch
4.89%
Ma50ch
-6.76%
Price vs 200-day SMA
-24.77%
RSI
40.2
RSI Monthly
26.61
RSI Weekly
27.68
Sharpe ratio
-1.63x
Sortino ratio
-1.85
Total Return
5.49%
Tr YTD
-25.49
Tr1m
-4.99%
Tr1w
-0.15%
Tr3m
-18.48%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
EUR 1B
Operating Income Growth
3.5
Operating Income Growth Q
-3.29
Operating Income Growth3 Y
2.81
Operating Income Growth5 Y
5.31
Operating margin
27.46

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
143,383,776%
Net Borrowing
15,647,522.9
Shares Insiders
5.33%
Shares Institutions
22.65%
Shares Qo Q
-0.18%
Shares Yo Y
0.17%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

58
MetricValue
Adjusted FCF
EUR 732.5M
Average Volume
1,304.65x
Bv Per Share
8.21
CAPEX
EUR -187.5M
Ch10y
-19.53
Ch1m
-4.99
Ch1w
-0.15
Ch1y
-36.52
Ch3m
-18.48
Ch3y
-58.65
Ch5y
-59.67
Ch6m
-32.62
Change
0.15%
Change From Open
-0.95
Close
54.36
Days Gap
1.1
Depreciation Amortization
123,842,787.8
Dollar Volume
17,039.7
Earnings Date
2026-05-12
EBIT
EUR 1B
EBITDA
EUR 1.1B
EPS
EUR 2.37
F Score
7
FCF
EUR 732.5M
FCF EV Yield
4.77x
Financing CF
-678,587,807
Fiscal Year End
September
Founded
1,954
Graham Number
21.1466
Graham Upside
-61.16
Income Tax
EUR 293.2M
Investing CF
-204,861,749
Is Primary Listing
0
Last Earnings Date
2026-02-06
Last Report Date
2025-12-31
Lynch Fair Value
EUR 11.98
Lynch Upside
-77.99
Ma150
69.43
Ma150ch
-21.59%
Ma20
56.1
Ma20ch
-2.96%
Net CF
29,323,348
Next Earnings Date
2026-05-12
Open
54.96
P FCF Ratio
16.56
P OCF Ratio
13.19
Payment Date
2025-12-09
Position In Range
45.83
Ppne
979,240,704.7
Price Date
2026-05-08
Price EBITDA
EUR 10.56
Relative Volume
0.23x
Revenue
3,734,509,178x
Tax By Revenue
7.85x
Tax Rate
35.44%
Tr6m
-30.5%
Volume
313
Z Score
4.11
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

ETR/CBHD dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+5.7%
$3.08 annual per share
Payout ratio
+130.0%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+5.0%
10 consecutive years of growth
Total shareholder yield
+5.5%
Next ex-dividend date: 2025-12-05
Performance

ETR/CBHD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-34.0%
S&P 500 1Y: n/a
3Y total return
-54.7%
S&P 500 3Y: n/a
5Y total return
-54.0%
S&P 500 5Y: n/a
10Y total return
-4.3%
S&P 500 10Y: n/a
Ownership

Who owns ETR/CBHD?

Insider, institutional, and short-interest positioning.

Institutional ownership
+22.6%
Share of float held by funds and institutions
Insider ownership
+5.3%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.2%
Negative means the company is buying back shares.
Technical

ETR/CBHD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
40.2
Neutral momentum band
Price vs 200-day MA
-24.8%
50/200-day relationship not available
Beta (5Y)
0.50
Less volatile than the market
Sharpe ratio
-1.63
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About ETR/CBHD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/CBHD stock rating?

etr/CBHD is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/CBHD analysis?

The full report lives at /stocks/etr/CBHD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/CBHD?

The latest report frames etr/CBHD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/CBHD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.